================================================================================
U.S. Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(D) of the Securities Exchange Act of 1934
DATE OF REPORT (Date of Earliest Event Reported)
March 23, 2005
--------------------------------------------------------------------------------
MEDCOM USA, INCORPORATED
(Name of small business issuer as specified in its charter)
DELAWARE 0-25474 65-0287558
State of Incorporation Commission File No IRS Employer Identification No.
7975 NORTH HAYDEN ROAD, SUITE D-333
SCOTTSDALE, AZ 85258
(Address of principal executive offices)
(480) 675-8865
(Issuer's telephone number)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2 (b) under the
Exchange Act (17 CFR 240.14d-2 (b) )
[ ] Pre-commencement communications pursuant to Rule 13e-4 (c) under the
Exchange Act (17 CFR 240.13e-4 (c) )
SECTION 8 - OTHER EVENTS
ITEM 8.01 OTHER EVENTS.
MedCom USA, Inc. completed an agreement to become a direct credit card
Independent Sales Organization (ISO) for National Processing Company (NPC) a
wholly owned subsidiary of Bank of America for the processing of credit/debit
card transactions.
This agreement allows MedCom USA, Inc. to bypass any intermediaries
providing credit card processing and deal directly with the first level of the
Merchant Bank's processors. This increases the profit margin for MedCom USA on
these transactions substantially.
This will allow MedCom USA more flexibility in engaging strategic
distribution partnerships with major sales organizations, healthcare carriers,
healthcare suppliers and other groups servicing the Medical and Dental
industries by providing them the ability to compensate these organizations
through residual sales income.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDCOM USA, INC.
By /s/ W.P. Williams
-----------------
Chairman, President, CEO
(Sole executive officer of the registrant)
March 23, 2005